Blocking sclerostin by a monoclonal antibody in human tumor necrosis factor transgenic (hTNFtg) mice model of arthritis reduces loss of systemic bone mass, periarticular bone destruction and cartilage damage, without any effect on inflammation. The gene discussed is TNF; the disease is Arthritis.